
Episode 16 | Why This CRISPR Founder Built a Biotech Without VC Money (Tilmann Burckstummer)
Tilmann Bürckstümmer co-founded Myllia Biotechnology in Vienna in 2018 and never raised venture capital. Not because he couldn't. Because the money would have cost more than it was worth. The reasoning is specific. A VC
























